Radical medicine: treating ageing to cure disease
- PMID: 16227974
- DOI: 10.1038/nrm1763
Radical medicine: treating ageing to cure disease
Abstract
The incidence of many diseases rises sharply with age. Although clearly separable, ageing and certain age-related diseases might share common mechanisms. Cellular metabolism and subsequent generation of reactive oxygen species might contribute both to the rate at which we age and to our susceptibility to numerous chronic diseases, therefore therapies that directly target the ageing process might provide new ways to treat human diseases.
Similar articles
-
Metal-independent putative superoxide dismutase mimics in chemistry, biology, and medicine.Ecotoxicol Environ Saf. 1996 Jul;34(2):141-4. doi: 10.1006/eesa.1996.0055. Ecotoxicol Environ Saf. 1996. PMID: 8812179 Review.
-
Franklin H. Epstein Lecture: Sirtuins, aging, and medicine.N Engl J Med. 2011 Jun 9;364(23):2235-44. doi: 10.1056/NEJMra1100831. N Engl J Med. 2011. PMID: 21651395 Review. No abstract available.
-
SOD isoforms and signaling in blood vessels: evidence for the importance of ROS compartmentalization.Arterioscler Thromb Vasc Biol. 2005 May;25(5):887-8. doi: 10.1161/01.ATV.0000164043.24549.50. Arterioscler Thromb Vasc Biol. 2005. PMID: 15863719 No abstract available.
-
An Introduction to a Special Issue of Free Radical Biology and Medicine - "Reactive Oxygen Species and Musculoskeletal Aging".Free Radic Biol Med. 2019 Feb 20;132:1-2. doi: 10.1016/j.freeradbiomed.2018.12.038. Free Radic Biol Med. 2019. PMID: 30665616 No abstract available.
-
Mitochondria induce oxidative stress, generation of reactive oxygen species and redox state unbalance of the eye lens leading to human cataract formation: disruption of redox lens organization by phospholipid hydroperoxides as a common basis for cataract disease.Cell Biochem Funct. 2011 Apr;29(3):183-206. doi: 10.1002/cbf.1737. Epub 2011 Mar 7. Cell Biochem Funct. 2011. PMID: 21381059
Cited by
-
Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction.Pharmacol Rev. 2023 May;75(3):487-520. doi: 10.1124/pharmrev.122.000629. Epub 2023 Jan 20. Pharmacol Rev. 2023. PMID: 36669831 Free PMC article. Review.
-
Advances in Human Mitochondria-Based Therapies.Int J Mol Sci. 2022 Dec 29;24(1):608. doi: 10.3390/ijms24010608. Int J Mol Sci. 2022. PMID: 36614050 Free PMC article. Review.
-
Chalcone Derivatives with a High Potential as Multifunctional Antioxidant Neuroprotectors.ACS Omega. 2022 Oct 18;7(43):38254-38268. doi: 10.1021/acsomega.2c05518. eCollection 2022 Nov 1. ACS Omega. 2022. PMID: 36340167 Free PMC article. Review.
-
Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders.Curr Neuropharmacol. 2023;21(5):1165-1183. doi: 10.2174/1570159X20666220830112408. Curr Neuropharmacol. 2023. PMID: 36043795 Free PMC article. Review.
-
Physiological and Molecular Characterization of an Oxidative Stress-Resistant Saccharomyces cerevisiae Strain Obtained by Evolutionary Engineering.Front Microbiol. 2022 Feb 24;13:822864. doi: 10.3389/fmicb.2022.822864. eCollection 2022. Front Microbiol. 2022. PMID: 35283819 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
